HEALTH CARE NEWSLETTER: Democrat push on insulin faces rule hurdle
Democrats want to make insulin a major part of drug pricing legislation set to pass this week, but face a Senate rules hurdle, lawmakers said.
Democratic leaders want to restore two major provisions of their drug pricing language, Sen. Jeanne Shaheen (DN.H.), said Tuesday. One would automatically subject insulin products to government negotiations for lower prices and the other would cap what people pay out of pocket for insulin at $35 a month.
Senate Majority Leader chuck schumer (DN.Y.) told reporters Tuesday that the limit would apply to both health plans and private insurance plans. However, Senate rules may limit the Medicare spending cap, Shaheen warned. For this reason, and to address the complicated issue of how rebates affect insulin prices, Shaheen said she hopes to pass a bipartisan measure that would include some of these provisions. Learn more about Alex Ruoff.
- Manchin, Sinema Speak: Sen. Joe Manchin (DW.Va.) discussed the $433 billion tax, climate and health plan with the would-be senator. Kirsten Sinema (D-Arizona), but gave no indication that he had secured a commitment from his backer. Erik Wasson has more.
It also happens on the Hill
WEDNESDAY HILL HEARINGS
- Organ procurement network: The Senate Finance Committee is holding a hearing Wednesday on “organizational failures” of the nation’s organ procurement and transplant network.
- Genetic medical research: The Senate Homeland Security Subcommittee on Emerging Threats is holding a hearing Wednesday on applying lessons from the Covid pandemic to gain-of-function research, an area of medical research that involves modifying viruses and of pathogens. The National Institutes of Health said in an email that they were not invited to the hearing, reports Jeannie Baumann.
The “Burn Pit” bill is passed in the Senate: Legislation (S. 3373) giving veterans exposed to toxic combustion fireplaces access to expanded health benefits was approved by Congress in an 86-11 Senate vote Tuesday night. The bill eventually won the support of 37 GOP senators and is now heading to President Joe Biden for his signature. Learn more about Diego Areas Munhoz.
Abortion in post-Roe America
Biden will sign another executive order on abortion access: President Joe Biden will sign a second executive order on Wednesday aimed at improving access to abortion services more than five weeks after the U.S. Supreme Court allowed states to largely ban them. The order will direct the Secretary of Health and Human Services to consider actions to help patients travel out of state for abortions using Medicaid funds, a decision conservatives are likely to challenge in court. Nancy Cook and Shira Stein cover the latest.
DOJ sues Idaho over six-week abortion ban: The Justice Department has filed a lawsuit against Idaho over the state’s six-week abortion ban law, arguing that federal law requires doctors and hospitals to perform medically necessary abortions to preserve the health of the pregnant person. The lawsuit, filed in the U.S. District Court for the District of Idaho, is the White House’s first legal action against states that have restricted access to abortion following the reversal of the decision of the Supreme Court in Roe v. Wade.
The filing argues that the federal Emergency Medical Treatment and Labor Act, which requires physicians to perform medically stabilizing abortions in emergencies, overrides state law. “The lawsuit seeks to declare invalid the state’s criminal prohibition on providing abortions to women who suffer from emergencies,” Attorney General Merrick Garland said at a Tuesday news conference in Washington. Learn more about Shira Stein.
HHS seeks to strengthen the confidentiality of abortion patients: The Biden administration’s efforts to protect reproductive health information from law enforcement after Dobbs hinges on how much authority its health agency has to pre-empt state criminal laws — a thorny issue for law enforcement officials. health lawyers. Allie Reed and Christopher Brown have more.
LEARN MORE ABOUT ABORTION RIGHTS
- Kentucky Abortion Ban: A Kentucky abortion provider suffered a setback in a case seeking to overturn two near-total abortion bans, as a state appeals court lifted an order that had allowed him to resume execution of procedures in the State. Mary Anne Pazanowski has more.
- Kansas Abortion Vote: The unusual decision to ask a question about abortion in a primary ballot backfired on Tuesday when Kansas voters rejected a proposal to amend the state Constitution to declare that there is no has no right to abortion. Alex Ebert has more.
- Anti-abortion group taxes: Forty congressional Democrats have called on the IRS and the Treasury Department to review the tax-exempt status of the anti-abortion Family Research Council. “The FRC is an example of an alarming trend over the past decade: right-wing advocacy groups self-identifying as ‘churches’,” they said. Read more from Erin Slowey.
Industry and Legal Health News
Highly Effective Fourth Dose of Pfizer: Hospital workers who received a fourth dose of Pfizer’s mRNA vaccine were much less likely to contract Covid than their triple-vaccinated peers in one study. The results published Tuesday in the open-access journal of the American Medical Association are the latest to confirm the benefits of a second booster against breakthrough infections caused by the omicron variant. The study authors pointed to an extra dose as a tool to prevent medical staff shortages. Dong Lyu has more.
Vaping Group Siding With FDA on Menthol: The FDA has gained an unlikely ally in its plan to ban menthol cigarettes and flavored cigars: a prominent vaping trade group that wants to see smokers switch to e-cigarette products. The Vapor Technology Association says it supports the proposals if the FDA allows more e-cigarettes as an alternative. Read more from Céline Castronuovo.
Teva faces Adderall supply disruptions: Teva Pharmaceutical, the biggest seller of Adderall in the United States, is experiencing “supply disruptions” of the popular ADHD drug at a time when demand is at its highest, a spokesperson said. the society. Learn more about Ike Swetlitz.
WHAT TO KNOW TODAY
- Antitrust help leaving: White House adviser Tim Wu, who helped shape the administration’s agenda to bolster economic competition in sectors including health care, is expected to step down in the coming months, according to people familiar with the movement. Learn more about Emily Birnbaum, Leah Nylen and Nancy Cook.
- The CEO defends the merger: Change Healthcare CEO Neil de Crescenzo defended the company’s proposed combination with UnitedHealth Group in court on Tuesday as Justice Department lawyers tried to prove the deal would harm competition, John Tozzi reports.
- Lawsuit for defamation of the doctor: A Texas doctor who stood on the steps of the US Supreme Court and gave a speech touting hydroxychloroquine as a treatment for Covid-19 has lost a libel suit against CNN, after a federal court of Texas said she had not shown the network’s claims to be untrue. Mary Anne Pazanowski has more.
- BGOV HHS Outsourcing Profile: HHS is consistently one of the top three civilian agencies to spend money on contracts over the past decade. Click here to download Kerry Burgott’s HHS agency profile.
With the help of Jeannie Baumann
To contact the reporter on this story: Brandon Lee in washington at [email protected]